systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»10.26442/2075-082X_2018.3.39-43systhiper-557Research ArticleСТАТЬИARTICLESОжирение как предиктор сердечно-сосудистых заболеваний: роль локальных жировых депоObesity as a predictor for cardiovascular disease development: role of localized fat depotАзимоваМ. О.AzimovaM. O.m.azimova@doconcall.ruБлиноваН. В.BlinovaN. V.nat-cardio1@yandex.ruЖернаковаЮ. В.ZhernakovaYu. V.juli001@mail.ruЧазоваИ. Е.ChazovaI. E.c34h@yandex.ruФГБУ «НМИЦ кардиологии»РоссияA.L.Myasnikov Institute of Clinical Cardiology National Medical Research Center of Cardiology of the Ministry of Health of the Russian FederationRussian Federation2018231220221533943Copyright © Азимова М.О., Блинова Н.В., Жернакова Ю.В., Чазова И.Е., 20222022Азимова М.О., Блинова Н.В., Жернакова Ю.В., Чазова И.Е.Azimova M.O., Blinova N.V., Zhernakova Y.V., Chazova I.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/557

В настоящее время отмечается неуклонный рост распространенности ожирения во всем мире. Известно, что именно висцеральное ожирение ассоциировано с высоким риском сердечно-сосудистых заболеваний и осложнений, однако доступные методы его верификации неточно отражают истинный объем висцеральной жировой ткани. В обзоре обсуждается значение локальных жировых депо как фактора риска сердечно-сосудистых заболеваний и раненного маркера поражения органов-мишеней у больных с ожирением. Рассматривается вариант использования толщины эпикардиального жира, оцениваемый методом эхокардиографии, как аналог окружности талии для более точной оценки наличия висцерального ожирения в рутинной практике.

At present a steady increase of obesity prevalence is observed all over the world. It is known that specifically visceral obesity is associated with high risk of cardiovascular disease and their complications development, but the available verification methods do not determine the real visceral adipose tissue volume accurately. The importance of localized fat depot as a risk factor for cardiovascular diseases and as an early marker of target organs damage in obese patients is discussed in the review. An alternative method of epicardial adipose tissue thickness determined with the use of echocardiography used as waist circumference analogue for a more precise evaluation of visceral obesity in everyday practice is reviewed.

ожирениевисцеральный эктопический жирлокальные жировые депоэпикардиальная жировая тканьпаранефральная жировая тканьсердечно-сосудистые заболеванияobesityvisceral ectopic fatlocalized fat depotepicardial adipose tissueparanephral adipose tissuecardiovascular diseaseReferencesObesity and overweight. Report of a WHO Consultation on Obesity. WHO Technical report Series, 2016.Obesity and overweight. Report of a WHO Consultation on Obesity. WHO Technical report Series, 2016.Ogden C.L, Carroll M.D, Lawman H.G et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016; 315: 2292-9. DOI: 10.1001/jama.2016.6361Ogden C.L, Carroll M.D, Lawman H.G et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016; 315: 2292-9. DOI: 10.1001/jama.2016.6361Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013, a systematic analysis for the global burden of Disease Study 2013. Lancet 2014; 384: 766-81. DOI: 10.1016/S0140-6736(14)60460-8Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013, a systematic analysis for the global burden of Disease Study 2013. Lancet 2014; 384: 766-81. DOI: 10.1016/S0140-6736(14)60460-8Global Health Observatory Data Repository. Report WHO [Internet]. Geneva: World Health Organization, 2013 [cited 2015 Feb 12].Global Health Observatory Data Repository. Report WHO [Internet]. Geneva: World Health Organization, 2013 [cited 2015 Feb 12].Ефремова Ю.Е., Ощепкова Е.В., Жернакова Ю.В. и др. Факторы риска сердечно-сосудистых заболеваний у лиц с высоким нормальным артериальным давлением в Российской Федерации (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2017; 14 (1): 6-11.Ефремова Ю.Е., Ощепкова Е.В., Жернакова Ю.В. и др. Факторы риска сердечно-сосудистых заболеваний у лиц с высоким нормальным артериальным давлением в Российской Федерации (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2017; 14 (1): 6-11.Preventing and Managing the Global Epidemic of Obesity. Report of a WHO Consultation on Obesity. Geneva: WHO Technical report Series, 1997.Preventing and Managing the Global Epidemic of Obesity. Report of a WHO Consultation on Obesity. Geneva: WHO Technical report Series, 1997.Flegal K.M, Kit B.K, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309 (1): 71-82.Flegal K.M, Kit B.K, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309 (1): 71-82.Gami A.S, Witt B.J, Howard D.E et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-14.Gami A.S, Witt B.J, Howard D.E et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-14.Hubert H.B, Feinleib M, McNamara P.M et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983; 67: 968-77.Hubert H.B, Feinleib M, McNamara P.M et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983; 67: 968-77.Da naei G, Lu Y, Singh G.M et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014; 2 (8): 634-47. DOI: 10.1016/S2213-8587 (14)70102-0Da naei G, Lu Y, Singh G.M et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014; 2 (8): 634-47. DOI: 10.1016/S2213-8587 (14)70102-0Wassertheil-Smoller S, Fann C, Allman R.M et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med 2000; 160 (4): 494-500.Wassertheil-Smoller S, Fann C, Allman R.M et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med 2000; 160 (4): 494-500.Romero-Corral A, Montori V.M, Somers V.K et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368 (9536): 666-78.Romero-Corral A, Montori V.M, Somers V.K et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368 (9536): 666-78.Rakel D. Integrative Medicine - E-Book. Elsevier Health Sciences, 2017.Rakel D. Integrative Medicine - E-Book. Elsevier Health Sciences, 2017.Жернакова Ю.В., Чазова И.Е., Ощепкова Е.В. и др. Распространенность сахарного диабета в популяции больных артериальной гипертонией. По данным исследования ЭССЕ-РФ. Системные гипертензии. 2018. 15 (1): 56-62. DOI: 10.26442/2075-082X_15.1.56-62Жернакова Ю.В., Чазова И.Е., Ощепкова Е.В. и др. Распространенность сахарного диабета в популяции больных артериальной гипертонией. По данным исследования ЭССЕ-РФ. Системные гипертензии. 2018. 15 (1): 56-62. DOI: 10.26442/2075-082X_15.1.56-62Cornier M.A, Després J.P, Davis N et al. Assessing Adiposity: A Scientific Statement From the American Heart Association. Circulation 2011; 124 (18): 1996-2019. DOI: 10.1161/CIR.0b013e318233bc6aCornier M.A, Després J.P, Davis N et al. Assessing Adiposity: A Scientific Statement From the American Heart Association. Circulation 2011; 124 (18): 1996-2019. DOI: 10.1161/CIR.0b013e318233bc6aБуторова Е.А., Елфимова Е.М., Шария М.А. и др. Возможности магнитно-резонансной томографии в оценке мягких тканей вокруг верхних дыхательных путей у больных с ожирением и синдромом обструктивного апноэ во время сна. Вестн. рентгенологии и радиологии. 2017; 98 (2): 79-85. https: //doi.org/10.20862/0042-4676-2017-98-2-79-85Буторова Е.А., Елфимова Е.М., Шария М.А. и др. Возможности магнитно-резонансной томографии в оценке мягких тканей вокруг верхних дыхательных путей у больных с ожирением и синдромом обструктивного апноэ во время сна. Вестн. рентгенологии и радиологии. 2017; 98 (2): 79-85. https: //doi.org/10.20862/0042-4676-2017-98-2-79-85Santanasto A.J, Goodpaster B.H, Kritchevsky S.B. Body Composition Remodeling and Mortality: The Health Aging and Body Composition Study Journals of Gerontology: Medical Sciences cite as. J Gerontol A Biol Sci Med Sci 2017; 72 (4): 513-9. DOI: 10.1093/gerona/glw163Santanasto A.J, Goodpaster B.H, Kritchevsky S.B. Body Composition Remodeling and Mortality: The Health Aging and Body Composition Study Journals of Gerontology: Medical Sciences cite as. J Gerontol A Biol Sci Med Sci 2017; 72 (4): 513-9. DOI: 10.1093/gerona/glw163Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно- сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 54 (10): 4-10. DOI: https: //dx.doi.org/10.18565/cardio.2014.10.4-12Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно- сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 54 (10): 4-10. DOI: https: //dx.doi.org/10.18565/cardio.2014.10.4-12Yui H, Otagiri K, Nakamura C еt al. Impact of gender difference on abdominal fat accumulation and coronary artery disease severity stratified by computed tomography-derived SYNTAX score. Eur Heart J 2017.Yui H, Otagiri K, Nakamura C еt al. Impact of gender difference on abdominal fat accumulation and coronary artery disease severity stratified by computed tomography-derived SYNTAX score. Eur Heart J 2017.Стародубова А.В., Кисляк О.А. Ожирение как фактор риска сердечно-сосудистых заболеваний. Обзор литературы. Фарматека. 2015; 17 (310): 28-35.Стародубова А.В., Кисляк О.А. Ожирение как фактор риска сердечно-сосудистых заболеваний. Обзор литературы. Фарматека. 2015; 17 (310): 28-35.Xia N, Li H. The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol 2017; 174 (20): 3425-42. DOI: 10.1111/bph.13650Xia N, Li H. The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol 2017; 174 (20): 3425-42. DOI: 10.1111/bph.13650Fernández-Alfonso M.S, Gil-Ortega M, García-Prieto C.F et al. Mechanisms of Perivascular Adipose Tissue Dysfunction in Obesity. Int J Endocrinol 2013; 2013: 1-8. DOI: 10.1155/2013/402053Fernández-Alfonso M.S, Gil-Ortega M, García-Prieto C.F et al. Mechanisms of Perivascular Adipose Tissue Dysfunction in Obesity. Int J Endocrinol 2013; 2013: 1-8. DOI: 10.1155/2013/402053Narayan K.M, Boyle J.P, Geiss L.S et al. Impact of recent increase in incidence on future diabetes burden: U.S. 2005-2050. Diabetes Care 2006; 29 (9): 2114-6.Narayan K.M, Boyle J.P, Geiss L.S et al. Impact of recent increase in incidence on future diabetes burden: U.S. 2005-2050. Diabetes Care 2006; 29 (9): 2114-6.Kopelman P.G. Obesity as a medical problem. Nature 2000; 404 (6778): 635-43.Kopelman P.G. Obesity as a medical problem. Nature 2000; 404 (6778): 635-43.Montani J.P, Carroll J.F, Dwyer T.M et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Dis 2004; 28 (Suppl. 4): S58-65. DOI: 10.1038/sj.ijo.0802858Montani J.P, Carroll J.F, Dwyer T.M et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Dis 2004; 28 (Suppl. 4): S58-65. DOI: 10.1038/sj.ijo.0802858Axelsson J, Moller H.J, Witasp A et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006; 48: 916-25.Axelsson J, Moller H.J, Witasp A et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006; 48: 916-25.Kurella M, Luan J, Lash J.P et al. Self-assessed sleep quality in chronic kidney disease. Int Urol Nephrol 2005; 37 (1): 159-65. DOI: 10.1007/s11255-004-4654-zKurella M, Luan J, Lash J.P et al. Self-assessed sleep quality in chronic kidney disease. Int Urol Nephrol 2005; 37 (1): 159-65. DOI: 10.1007/s11255-004-4654-zKnight S.F, Imig J.D. Obesity, insulin resistance, and renal function. Microcirculation 2007; 14: 349-62.Knight S.F, Imig J.D. Obesity, insulin resistance, and renal function. Microcirculation 2007; 14: 349-62.Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity 2009; 17: 625.Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity 2009; 17: 625.Owan T.E, Redfield M.M. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 320-32.Owan T.E, Redfield M.M. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 320-32.Kossaify A, Nicolas N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol 2013; 7: 43-50.Kossaify A, Nicolas N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol 2013; 7: 43-50.Hatem S.N, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 2014; 102: 205-13.Hatem S.N, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 2014; 102: 205-13.Mahmood S.S, Levy D, Vasan R.S et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014; 383 (9921): 999-1008. DOI: 10.1016/S0140-6736 (13)61752-3Mahmood S.S, Levy D, Vasan R.S et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014; 383 (9921): 999-1008. DOI: 10.1016/S0140-6736 (13)61752-3Mazurek T, Zhang L.F, Zalewski A. et al. Human epicardial adipose tissue is a source of inflammatory markers. Circulation 2003; 108: 2460-6.Mazurek T, Zhang L.F, Zalewski A. et al. Human epicardial adipose tissue is a source of inflammatory markers. Circulation 2003; 108: 2460-6.Baker A.R, Silva N.F, Quinn D.W et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabet 2006; 5: 1.Baker A.R, Silva N.F, Quinn D.W et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabet 2006; 5: 1.Hirata Y, Tabata M, Kurobe H et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248-55.Hirata Y, Tabata M, Kurobe H et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248-55.Park H, Choi S et al. Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2 dimensional echocardiography. BMC Cardiovasc Dis 2014; 14: 3.Park H, Choi S et al. Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2 dimensional echocardiography. BMC Cardiovasc Dis 2014; 14: 3.Дружилов М.А., Бетелева Ю. Е., Кузнецова Т.Ю. Толщина эпикардиального жира - альтернатива окружности талии как самостоятельный или второй основной критерий метаболического синдрома? Рос. кардиол. журн. 2014; 3 (107): 76-81.Дружилов М.А., Бетелева Ю. Е., Кузнецова Т.Ю. Толщина эпикардиального жира - альтернатива окружности талии как самостоятельный или второй основной критерий метаболического синдрома? Рос. кардиол. журн. 2014; 3 (107): 76-81.Iacobellis G, Ribaudo M, Assael F et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88 (11): 5163-8.Iacobellis G, Ribaudo M, Assael F et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88 (11): 5163-8.

The authors declare that there are no conflicts of interest present.